Northwire Canada EditionTuesday, July 14, 2026
Northwire
WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8% WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8%
M&A / Property

Eshbal firms up Dare to be Different acquisition

ESBL · Price

Executive Summary

  • Eshbal Functional Food Inc. has signed a definitive share purchase agreement to acquire a 55% majority interest in Dare to be Different Foods Inc. (D2BD), a US-based gluten-free food company.
  • The transaction involves a combination of cash and equity consideration, with Eshbal paying $248,000 USD in cash and issuing 1.2 million of its own shares valued at $180,000 USD.
  • The acquisition is part of Eshbal’s strategy to expand its North American footprint and consolidate brands in the gluten-free and "better-for-you" market segments.

Key Details

  • Transaction Structure: Eshbal acquires 55% equity stake in D2BD.
  • Cash Consideration: Aggregate cash payment of $248,000 USD.
    • Initial payment due on closing.
    • Remaining payments to be made over a 12-month period.
  • Equity Consideration: Issuance of 1.2 million common shares of Eshbal to D2BD shareholders.
    • Valued at $180,000 USD.
    • Issue price set at 15 US cents per share (noted as 21 cents on a pro-rata basis based on the last closing price on the TSX Venture Exchange prior to execution).
  • Earn-out Provision: Eshbal may issue additional shares to D2BD shareholders subject to the attainment of certain performance milestones over a two-year period from closing.
  • Target Company Profile (D2BD):
    • Specializes in gluten-free, vegetable-forward food products (pizzas, gnocchi, crisps made from cauliflower and broccoli).
    • Products available in over 500 stores, including Walmart locations in New York and local stores in New York, New Jersey, and Connecticut.
  • Closing Conditions:
    • Entry into a consulting agreement with a key D2BD executive.
    • Receipt of regulatory approvals, including TSX Venture Exchange.
    • Representations and warranties remaining true and correct.
    • Completion of covenants and obligations.
  • Expected Closing: Early December 2025.
  • Share Restrictions: Issued shares are under prospectus exemptions (National Instrument 45-106) with a statutory hold period of four months and one day.
  • Fees: No finders' fees payable.
  • Liabilities: Eshbal is not assuming any long-term liabilities of D2BD.
  • Strategic Rationale: Enhances access to synergistic product lines, retail distribution, local production facilities, and an experienced US management team.

Notable Quotes

  • "Dare to Be Different Foods was built on simple, great-tasting ingredients and a fanatical focus on quality. Partnering with Eshbal opens the door to broader distribution, disciplined execution, as well as the resources to scale our most-loved products. We're excited about what this collaboration can unlock for retailers and consumers alike," — Marvin Jemal, Managing Director, Dare to be Different Foods.
  • "The USA is the largest gluten-free market in the world, with growth continuing to be more than double that of overall grocery industry. This acquisition strengthens our North American footprint with a like-minded, high-quality brand," — Avi Markus, Chief Commercial Officer, Eshbal.
Read the original news release →

More from Eshbal Functional Food Inc